Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabio Ciceri and Sara Mastaglio.
Fabio Ciceri
Connection Strength
1.399
Sara Mastaglio
  1. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020 06; 215:108450.
    View in: PubMed
    Score: 0.879
  2. COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome. Bone Marrow Transplant. 2021 09; 56(9):2312-2315.
    View in: PubMed
    Score: 0.238
  3. Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase. Hemasphere. 2020 Aug; 4(4):e448.
    View in: PubMed
    Score: 0.224
  4. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020 11; 220:108598.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.